Skip to main content
. 2022 May 28;60(1):997–1010. doi: 10.1080/13880209.2022.2067568

Figure 3.

Figure 3.

Lupenone improves the lipid metabolic disorder in rats with diabetes. Lupenone decreases the FFA (a), TC (b) and TG (c) levels. Lupenone has no significantly effect on the levels of LDL-C (d) and HDL-C (e), but the 2.0 mg/kg lupenone could decrease the TC/HDL-C (f) ratio. Data are presented as means ± SD. N = 9–10 there are nine rats in normal group, whereas and 10 rats in the other groups. *p< 0.05 vs. the T2DM group, #p< 0.05 vs. the normal group. SD: standard deviation.